Gibson focuses his practice on providing counsel to his clients in all aspects of foreign and domestic patent prosecution, interference proceedings, and post-issuance reissue and reexamination in the biotechnology, medical device, chemical, and pharmaceutical industries. Gibson uses extensive scientific background in immunology and microbiology to provide guidance to his clients on a variety of intellectual property matters. Additionally, he prepares and evaluates licensing agreements, non-infringement, invalidity, patentability, and freedom to operate opinions, as well as counsels clients in due diligence matters.
For clients in the biotechnology industry, Gibson advises and prosecutes patents for vaccines, immunological therapies, DNA and protein therapeutics, antibodies, stem cells, immunological screens, biomarkers, transgenic animals, gene therapy, molecular and cellular biological screening assays, diagnostic assays, diagnostic sensors, and peptide/protein therapy. Gibson’s biotechnology experience extends to medical devices, advising clients on surgical devices, implants, medical imaging, sensors, and bioreactors.
Gibson’s chemical and pharmaceutical experience includes protecting innovations in pesticides, polymers, plastics, composites, and controlled release vehicles.
Gibson is a member of the State Bar of Georgia and a board member of the Intellectual Property section of the Atlanta Bar Association. Gibson is also heavily involved in the Public Policy and Advocacy committee of the Association of University Technology Managers.
Memberships and Affiliations
- Atlanta Bar Association
- Member, Intellectual Property Section Board of Directors - 2013-present
- Secretary and Treasurer for the Intellectual Property Section
- American Association for the Advancement of Science
- Association of University Technology Managers (AUTM)
- Committee Member - Public Policy Legal Task Force - 2015-present
- Georgia Patents - board member
- Georgia State University Intellectual Property Advisory Board
Publications and Presentations
- Guest lecturer Emory University School of law, patent law, annually since 2015
- Guest lecturer University of Georgia School of law, patent law, annually since 2014
- Speaker “Master Class: Subject Matter Eligibility” Best Practices in Intellectual Property, Tel Aviv May 2014
- Speaker, "The Effect of the America Invents Act on Small Businesses," University of Rochester F.I.R.E lecture series, May 2012
- Guest Lecturer, Georgia State University School of Law, patent law, annually since 2008
- Guest Lecturer, Mercer University School of Law, patent law, annually since 2008
- Speaker, "Patenting Basics – The America Invents Act," University of Rochester F.I.R.E lecture series, November 2011
- Speaker, "Leahy-Smith, America Invents Act," Biotechnology Association of Alabama, November 2011
- Speaker, "Leahy-Smith, America Invents Act," HudsonAlpha Institute seminar, November 2011
- Lecturer, "Inequitable Conduct – Therasense, Inc. v. Beckton Dickinson & Co.," University of Rochester F.I.R.E series lectures, April 2011
- Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D., "Memory CD8 T-cell compartment grows in size with immunological experience." Nature. 2009 Jan 8; 457(7226): 196-9
- Speaker, "Giving Away the Farm – Why Material Transfer Agreements Matter in a University Setting," University of Rochester F.I.R.E lecture series, November 2009
- Qu D, Lanier G, Yuan ZH, Wen YM, Howard CR, Ahmed R., "Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice." J. Med. Virol. 2008 Feb; 80(2):225-32
- van der Most RG, Murali-Krishna K, Lanier JG, Wherry EJ, Puglielli MT, Blattman JN, Sette A, Ahmed R., "Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation." Virology. 2003 Oct 10; 315(1):93-102
- Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP, “Heterologous immunity provides a potent barrier to transplantation tolerance.” J. Clin Invest. 2003 Jun 111(12_: 1887-95
- Lecturer, "Reality IP: Why Patents Matter in the University Setting," University of Rochester F.I.R.E lecture series, June 2003
- Grayson JM, Laniewski NG, Lanier JG, Ahmed R., "Mitochondrial potential and reactive oxygen intermediates in antigen-specific CD8(+) T cells during viral infection." J. Immunol. 2003 May 1; 170(9):4745-51
- Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R., "Differential sensitivity of Naïve and Memory CD8+ T Cells to apoptosis in vivo." J. Immunol. 2002 Oct 1; 169(7):3760-70
- Suresh M, Lanier G, Large MK, Whitmire JK, Altman JD, Ruddle NH, Ahmed R.. "Role of LTa in T cell responses during an acute virol infection." J. Virol. 2002 Apr; 76(8):3943-51
- Lanier JG, Ahmed R, Pamer E., 2001. "Immunological Memory to Infection. In Immunology of Infectious Diseases." Stefan H.E. Kaufman, Alan Sher and Rafi Ahmed (eds.), ASM Press, Washington, D.C.
- Grayson JM, Lanier JG, Altman JD, Ahmed R., 2001. "The role of p53 in regulating antiviral T cell responses." p. 53. J. Immunol. 167:1333-1337
- Czar MJ, Kersh EN, Mijares LA, Lanier G, Lewis J, Yap G, Chen A, Sher A, Duckett CS, Ahmed R, Schwartzberg PL, 2001. "Altered lymphocyte responses and cytokine production in mice deficient in the x-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. PNAS." 98(13). 7449-7454
- Lanier JG, Newman MJ, Lee EM, Sette A, Ahmed R, 1999. "Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses." Vaccine. 18(5-6):549-57
- Of Counsel, Smith, Gambrell & Russell, LLP
- Patent Attorney, Ballard Spahr LLP
- Patent Attorney, Needle & Rosenberg
- Patent Agent, Needle & Rosenberg